COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Objective To evaluate the excess risk and relative hazards for developing incident clinical
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …

Background Thrombotic complications are considered among the main extrapulmonary
manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration of …

Thromboembolism is a common and deadly consequence of COVID-19 infection for
hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Background The study aimed to describe the epidemiology and outcomes of hospital-
acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically …

Background Venous thromboembolism (VTE) is a potentially fatal complication of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and thromboprophylaxis …

Background Comorbidities including ischemic heart disease (IHD) worsen outcomes after
SARS‐CoV‐2 infections. High lipoprotein (a)[Lp (a)] concentrations are a strong risk factor …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …